Iberdomide vs. Observation Post Ide-Cel CAR-T
Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 42 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
- Accepting patients
Mission Cancer MercyOne Cancer Center (Laurel)
Des Moines, IA
- Accepting patients
Cedars-Sinai Medical Center - UCLA School of Medicine
Samuel Oschin Comprehensive Cancer Institute
Los Angeles, CA
- Accepting patients
- Show Principal Investigator
Nebraska Medicine (Bellevue Medical Center)
Bellevue, NE
- Accepting patients
- Show Principal Investigator
Nebraska Medicine (Village Pointe)
Omaha, NE
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
Swedish - First Hill Campus
Seattle, WA
- Accepting patients
- Accepting patients
1,332 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.